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11 Abstract An accurate and easy method for the extraction,
12 cleanup, and HRGC-HRMS analysis of dioxin-like PCBs
13 (DL-PCBs) in low-volume serum samples (1 mL) was devel-
14 oped. Serum samples were extracted several times using n-
15 hexane and purified by acid washing. Recovery rates of la-
16 beled congeners ranged from 70 to 110 % and the limits of
17 detection were below 1 pg/g on lipid basis. Although human
18 studies are limited and contradictory, several studies have
19 shown that DL-PCBs can have adverse effects on the male
20 reproductive system. In this way, the present method was ap-
21 plied to 21 serum samples of male patients attending fertility
22 clinics. The total levels obtained for the patients ranged from
23 6.90 to 84.1 pg WHO-TEQ/g lipid, with a mean value of
24 20.3 pg WHO-TEQ/g lipid. The predominant PCBs (the
25 sum of PCB 118, 156, and 105) contributed 67 % to the mean
26 concentration of total DL-PCBs in the samples analyzed.
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29Introduction
30The possible relationship between environmental and occupa-
31tional exposure to toxic substances and the decreasing quality of
32semen and the consequent increase inmale infertility is a subject
33of great scientific interest (Rubes et al. 2005). Several laboratory
34animal studies have indicated that some endocrine disruptors as
35polychlorinated biphenyls (PCBs), polychlorinated dibenzo-p-
36dioxins (PCDDs), and polychlorinated dibenzofurans (PCDFs)
37may affect human reproduction and may be linked to reduced
38fertility in women and men (Cok et al. 2008).
39The World Health Organization has estimated that nearly
408 % of couples around the world present some forms of infer-
41tility problems during their reproductive lives. This means that
4250 to 80 million people suffer fertility problems (Woodruff
43et al. 2010). Specially, there are evidence for decreasing qual-
44ity of semen during the last decades (Carlsen et al. 1992).
45Environmental factors (exposure to traffic exhaust fumes, di-
46oxins, combustion products, etc.) and several lifestyles as obe-
47sity and smoking could negatively affect human fertility,
48underlining the importance of environmental and lifestyle im-
49pacts throughout the life course (Sharpe 2010).
50Their lipophilic nature, low biodegradability, and chemical
51stability, together with the indiscriminate use of dioxin-
52contaminated PCBs, ensure their ubiquity and persistence in
53the environment (Esposito et al. 2014). Exposure of the general
54population to dioxin-like PCBs occurs mainly through food,
55and also dermal contact and inhalation. In order to quantify
56trends and patterns of human exposure to chemical agents,
57monitoring programs play a fundamental role (Angerer et al.
582007; Needham et al. 2007; Patterson et al. 2009; Viso et al.
592009). Moreover, monitoring programs act as a framework to
60evaluate health impacts and the effectiveness of public and
61private policies aimed at decreasing exposure to POPs (Depart-
62ment of Health and Human Services 2009; Viso et al. 2009).
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63 There is little information on infertility and related condi-
64 tions on human exposure to DL-PCBs, most of the papers
65 published are relating to the presence of others PCBs conge-
66 ners in different fluids of the human reproductive tract such as
67 the seminal fluid, cervical mucus, and follicular fluid.
68 Nowadays, there is an increasing demand to reduce the size
69 of the specimen collected for human biomonitoring (Patterson
70 et al. 2011). In this way, there are several studies analyzing the
71 DL-PCBs content in serum samples from different group of
72 populations; however, there are scarce studies reporting the
73 analysis of serum from individuals using low-volume sam-
74 ples, due to the difficulty in reaching the required selectivity
75 and sensibility for the analysis of these compounds.
76 The goal of this work is to develop an analytical method for
77 the analysis of small-volume human serum samples (1 mL) in
78 order to provide an individualized patient study. The optimi-
79 zation of the analytical method has been carried out consider-
80 ing these important aspects: minimizing both the consumption
81 of chemical reagents and analysis time, in order to minimize
82 the cost of the analysis, but keeping the quality standards
83 required for the analysis of dioxin-like PCBs.
84 Methods and materials
85 In this study, 21 blood serum samples were collected from
86 male patients recruited for assisted reproduction at the IVF
87 Spain Treatment Clinic from May 2012 to June 2014. The
88 age of the men ranged from 30 to 55 years and the body mass
89 index (BMI) ranged between 21.0 and 31.8 (mean 25.2). Gen-
90 eral information regarding age, place of residence, smoking
91 habits, dietary habits, and alcohol consumption, along with
92 occupational, residential, and clinical histories were collected.
93 Each patient provided an informed consent after receiving a
94 detailed explanation of the study and potential consequences
95 and signed an informed consent form.
96 Blood samples were obtained by venipuncture and collect-
97 ed in Vacutainer test tubes without anticoagulant and were
98 immediately transferred to a glass centrifuge tube. After cen-
99 trifugation and decantation, the serums were stored in the dark
100 at −20 °C until analysis.
101 The procedure used for analytical determination was
102 adapted from a previously published method (Grimalt et al.
103 2010) for the analysis by gas chromatography with electron
104 capture detection of several halogenated organic pollutants,
105 including seven PCB congeners (PCBs 28, 52, 101, 118,
106 138, 153, and 180).
107 From an analytical point of view, gas chromatography
108 (GC) coupled with magnetic sector high-resolutionmass spec-
109 trometry (HRMS) is the most sensitive and specific technique
110 in the field of ultra-trace measurement of dioxin-like PCB.
111 The use of isotope dilution methodology, based on 13C-la-
112 beled standards at a minimum mass resolution of 10,000
113resolving power in the selected ion monitoring (SIM) acqui-
114sition mode, allows enhanced selectivity and the lowest sen-
115sitivity threshold (Patterson et al. 2011). In this way, in this
116study, the extraction and cleanup with n-hexane and concen-
117trated sulfuric acid was followed by HRGC-HRMS determi-
118nation. Figure 1 shows the analytical procedure optimized for
119the determination of DL-PCBs in low-volume samples of hu-
120man serum. To improve the separation between aqueous and
121organic phases, 10 drops of Milli-Q water were added before
122sample centrifugation.
123The samples were analyzed using an Agilent HP5890 gas
124chromatograph equipped with programmable temperature va-
125porization (PTV) inlet, coupled to a Micromass Autospec
126Ultima-NT mass spectrometer. An Agilent DB5-MS chro-
127matographic column (60 m×0.25 mm i.d.×0.25 μm) was
128used for the analysis. Isotopically labeled standards were ob-
129tained fromWellington Laboratories Inc. (Canada). n-Hexane
130and sulfuric acid were for organic trace analysis and were
131purchased from Merck (Germany).
132Concentration of lipophilic pollutants in serum are usually
133expressed on a lipid weight basis instead of on a fresh weight
134basis, with a view to obtain biomarker values that reflect body
135burden of persistent organohalogen pollutants. In this work,
136the total lipid concentration was determined by the sum of the
137triglyceride and cholesterol concentrations, according to the
138following regression ( Q2Phillips et al. 1989):
139Total lipid (mg/dL)=62.3+triglycerides (mg/dL)+2.27∗
140total cholesterol (mg/dL)
141The levels of dioxin-like PCBs are expressed in picograms
142of compound per gram of lipid (pg/g lipid) and the toxic
143equivalents were calculated according to the toxic equivalen-
144cy factors published in 2005 by the World Health Organiza-
145tion (WHO2005-TEFs) (van den Berg et al. 2006).
146Samples were spiked with 13C-labeled internal standards
147before extraction and with 13C-labeled recovery standards be-
148fore HRGC-HRMS analysis. Recovery rates of labeled con-
149geners ranged from 70 to 110 % and the limits of detection
150were below 1 pg/g on lipid basis. Quality assurance criteria
151were based on the minimum requirements described in US
152EPA method 1668C for dioxin-like-PCBs (US EPA 2010).
153A procedural blank was associated with each batch of four
154samples and processed in the same manner. The congeners
155below the limit of detection (LOD) were calculated consider-
156ing a concentration equal to their respective LOD.
157Results and discussion
158In this study, DL-PCBs have been determined in 21 serum
159samples from male patients recruited for assisted reproduc-
160tion. Ten patients aged between 30 and 40 years and the rest
161aged between 41 and 55 years. The BMI was categorized into
162three groups: BMI <25, not overweight; BMI 25-29.9,
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Fig. 1 Scheme of the analytical procedure developed
t1:1Q3 Table 1 Levels of DL-PCB congeners in the blood serum, expressed as pg/g lipid, and total DL-PCB concentrations, expressed as pg WHO-TEQ/g
lipid
t1:2 Mean Median Standard deviation Minimum Maximum % above LOD % WHO-TEQ
t1:3 Non-ortho dioxin-like PCBs
t1:4 PCB 77 230 147 254 18.7 1110 81 0.14
t1:5 PCB 81 72.5 61.5 53.8 14.3 250 19 0.15
t1:6 PCB 126 138 88.9 156 41.2 638 57 65.6
t1:7 PCB 169 211 109 232 56.1 1010 81 30.1
t1:8 Mono-ortho dioxin-like PCBs
t1:9 PCB 105 527 394 315 137 1040 100 0.11
t1:10 PCB 114 147 117 100 34.2 387 76 0.03
t1:11 PCB 118 2170 1740 1270 462 5220 100 0.47
t1:12 PCB 123 138 87.8 94.3 23.0 368 62 0.03
t1:13 PCB 156 1080 886 716 196 2630 100 0.25
t1:14 PCB 157 269 227 180 85.5 823 95 0.06
t1:15 PCB 167 322 262 212 66.6 788 95 0.07
t1:16 PCB 189 345 244 337 103 1690 95 2.95
t1:17 Sum
t1:18 DL-PCB 5650 5210 2780 2020 13,200
t1:19 WHO-TEQ DL-PCB 20.3 11.6 22.4 6.90 84.1
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163 overweight; and BMI ≥30, obese. Only one patient had a BMI
164 >30, while for the rest of the patients, the number of not
165 overweight and overweight was the same. To describe the
166 levels of DL-PCBs, we calculated the medians and arithmetic
167 means, their standard deviations, the maximum and minimum
168 values, and the percentage of samples that present a concen-
169 tration above the limit of detection. An overview of the values
170 obtained is shown in Table 1.
171 The total levels of DL-PCBs obtained for the patients
172 ranged from 6.90 to 84.1 pg WHO-TEQ/g lipid, with a mean
173 value of 20.3 pg WHO-TEQ/g lipid. The predominant conge-
174 ners, in order, were PCB 118, PCB 156, and PCB 105, with
175 mean values of 2170, 1080, and 527 pg/g lipid, respectively.
176 The predominant PCBs (the sum of the three previously men-
177 tioned) contributed 67 % to the mean concentration of total
178 DL-PCBs in the samples analyzed. Two congeners, PCB 126
179 and PCB 169 contributed 96 % to the total WHO-TEQ value,
180 due to their high toxic equivalency factors. Themean value for
181 non-ortho PCBs was 20.2 pg WHO-TEQ/g lipid and for
182 mono-ortho PCBs 0.53 pg WHO-TEQ/g lipid. All the conge-
183 ners were detected in the samples, although PCB 81 was de-
184 tected only in 4 of the 21 samples analyzed. PCBs 118, 156,
185 and 105 were detected in all the serum samples.
186 The total TEQ at the 90th percentile of the US population
187 in NHANES 2003–2004 was 30.0 pg/g of lipid (Patterson
188 et al. 2009) for total dioxin-like compounds (PCDD/Fs and
189 DL-PCBs). Wittsiepe et al. (2007) found a total dioxin-like
190 compounds value of 28.36 pg TEQ/g lipid in the blood from
191 pregnant women.Q4 In a review of worldwide literature (works
192 published from 1989 until June 2010) (Consonni et al. 2012)
193in general populations not directly exposed to recognized
194emission sources, a mean value of 3.7 pg WHO-TEQ/g lipid
195for the mono-ortho and non-ortho PCBs is given. Several
196authors have studied the DL-PCBs in blood serum samples
197from populations living in industrial areas or near urban waste
198treatment or incineration plants. Zubero et al. (2009) com-
199pared the DL-PCBs in serum samples of different populations
200and found that the mean values ranged between 4.1 and
20115.6 pg WHO-TEQ/g lipid; the values obtained for the male
202patients facing fertility problems are higher than those present-
203ed by these studies.
204Boxplots with whiskers for DL-PCBs congeners distribu-
205tion are shown in Fig. 2. Boxes represent interquartile ranges
206(IQR), medians are marked in each box with a line, the whis-
207ker on the appropriate side is taken to 1.5·IQR from the quar-
208tile (the “inner fence”) and individual outlying data points are
209displayed as unfilled circles (for suspected outliers) or filled
210circles (for outliers). Suspected outliers are above 1.5·IQR and
211individual outlying data points are above 3·IQR. There are
212two serum samples analyzed that present several outliers
213values for different isomers, one serum for PCB 169, PCB
Fig. 2 Boxplots of median
values of DL-PCBs
t2:1Table 2 Concentratios of DL-PCBs (p WHO-TEQ/g lipid) in male
serum samples by age and BMI
t2:2Mean Median Minimum Maximum
t2:330–40 years 19.2 11.5 7.40 84.2
t2:441–55 years 21.3 11.4 6.90 83.9
t2:5BMI <25 29.9 17.8 6.90 84.2
t2:6BMI 25–29 11.9 11.1 7.40 19.2
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214 189, and PCB 126 and another sample for PCB 81, PCB 77,
215 and PCB 126.
216 Table 2 summarizes the concentrations of DL-PCBs
217 (pg WHO-TEQ/g lipid) in male serum samples by age and
218 BMI. Generally, the concentration of PCBs in human samples
219 tended to increase with age (Chen et al. 2013), which is con-
220 sistent with the fact that these compounds are liposoluble sub-
221 stances that accumulate in the adipose tissue. The results ob-
222 tained in this study are in accordance with this general trend,
223 although the values are quite similar in the two groups of age.
224 The role played by BMI has not yet been established and there
225 is controversy with respect to the direction of its association.
226 One of the main findings is that some of the PCBs are posi-
227 tively related to fat mass, while others show an opposite asso-
228 ciation. Typically the low-chlorinated PCBs were related to fat
229 mass in a positive way, while the opposite trend was generally
230 seen for the highly chlorinated compounds (Ronn et al. 2011).
231 In this study, overweight subjects had much lower mean
232 values than the normal weight patients; this could be ex-
233 plained by the distribution of a given body burden in a higher
234 amount of fat, so the lipid concentration is lower in the over-
235 weight patients.
236 PCBs have been associated with a range of adverse health
237 effects, including adverse effects on reproduction. However,
238 the human data available on this topic remain vague and large-
239 ly inconclusive (Meeker et al. 2011). Although there are sev-
240 eral studies that try to relate the serum concentrations of PCBs
241 (mainly analyzed by GC-ECD) with male and female fertility
242 problems, we have not found any study about the levels of
243 DL-PCBs in male serum samples of patients facing fertility
244 problems, and that makes the comparison of our results a quite
245 complicated task. Dallinga et al. (2002) analyzed PCB 118,
246 153, 138, and 180 in blood samples from a group of men with
247 very poor semen quality and another group with normal se-
248 men quality in order to determine whether a difference in these
249 levels could be established and found a significant relationship
250 between the combined levels of these PCBs and the corre-
251 sponding level in seminal plasma.
252 In this work, an analytical method for the analysis of
253 dioxin-like PCBs in low volume (1 mL) serum samples has
254 been carried out, obtaining an easy and cost-effective method
255 with appropriate detection limits. This method has allowed to
256 obtain the amount of DL-PCBs present in the serum of 21men
257 attending fertility clinics who suffer different fertility prob-
258 lems. Despite the limitations of our study, to the best of our
259 knowledge, this is the first study to investigate the levels of
260 DL-PCBs in the serum of male patients facing fertility prob-
261 lems. Further number of samples, having a better understand-
262 ing of the lifestyle of patients, and knowing other factors that
263 could affect the relationship between these pollutants and fer-
264 tility problems could be very useful. It would also be interest-
265 ing to compare the results of this study with serum samples
266 from fertile patients.
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